Yesterday, the Global Fund published its 2025 Results Report. Figures demonstrate how the partnership is meeting the global health funding crisis with steadfast commitment to its mission, while recognising the need to continue to evolve and adapt to the rapidly changing context.
Since its establishment, 70 million lives have been saved through the Global Fund partnership. In 2024, for the first time in a single year, over 1 million people received pre-exposure prophylaxis (PrEP) against HIV. Prevention against TB has continued to grow, with 3.4 million people receiving preventive therapy in 2024. In just five years, the number of children protected from malaria through seasonal chemoprevention has doubled, reaching 50.9 million in 2024. In addition, countries’ co-financing commitments have increased by 20% compared to the previous cycle, clearly demonstrating greater ownership of national health responses.
Beyond these results, the Global Fund is also the largest provider of multilateral grants for health and community systems, with a US$2.7 billion investment in 2024. Its investment in human resources and the modernisation of health surveillance systems have supported scaled-up national responses to HIV, tuberculosis and malaria. For example, in 2024, the Global Fund invested US$294 million to expand and strengthen laboratory infrastructure and multi-disease diagnostic capacity across 85 countries, advancing global health security.
The Global Fund’s capacity to leverage its strategic strengths and adapt to a rapidly changing context can be seen in its support to countries facing the worst humanitarian crises. In countries like Ukraine, Sudan and Syria, the Global Fund supports the continuation of essential health services and delivery of lifesaving treatments.
As a leading voice for global health, the EU’s continued leadership is crucial. The Global Fund’s investment case is rooted in the shared belief that health is a fundamental human right. By empowering communities and strengthening health systems, the Global Fund is not only combating these specific diseases but also building more resilient societies capable of withstanding future shocks.
The Global Fund’s Eighth Replenishment offers the EU a critical opportunity to reinforce its role as a global health leader. A few EU Member States, including Luxembourg and Spain, have already expressed their increased support to the Global Fund. We urge the EU Member States, and the European Commission, in particular, to do the same.
We call on the European Commission to demonstrate its unwavering commitment to global health by pledging €800 million to the Global Fund. Investing in health has many benefits: ensuring brighter futures for all, expanding societies’ resilience, allowing communities to thrive, building more sustainable economies, and strengthening innovation. In a context of constrained resources, smart investment like this is not optional, it is essential.
;
